Back to Search Start Over

Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung.

Authors :
Faustino LD
Griffith JW
Rahimi RA
Nepal K
Hamilos DL
Cho JL
Medoff BD
Moon JJ
Vignali DAA
Luster AD
Source :
Nature immunology [Nat Immunol] 2020 Nov; Vol. 21 (11), pp. 1371-1383. Date of Electronic Publication: 2020 Sep 28.
Publication Year :
2020

Abstract

Foxp3 <superscript>+</superscript> regulatory T (T <subscript>reg</subscript> ) cells expressing the interleukin (IL)-33 receptor ST2 mediate tissue repair in response to IL-33. Whether T <subscript>reg</subscript> cells also respond to the alarmin IL-33 to regulate specific aspects of the immune response is not known. Here we describe an unexpected function of ST2 <superscript>+</superscript> T <subscript>reg</subscript> cells in suppressing the innate immune response in the lung to environmental allergens without altering the adaptive immune response. Following allergen exposure, ST2 <superscript>+</superscript> T <subscript>reg</subscript> cells were activated by IL-33 to suppress IL-17-producing γδ T cells. ST2 signaling in T <subscript>reg</subscript> cells induced Ebi3, a component of the heterodimeric cytokine IL-35 that was required for T <subscript>reg</subscript> cell-mediated suppression of γδ T cells. This response resulted in fewer eosinophil-attracting chemokines and reduced eosinophil recruitment into the lung, which was beneficial to the host in reducing allergen-induced inflammation. Thus, we define a fundamental role for ST2 <superscript>+</superscript> T <subscript>reg</subscript> cells in the lung as a negative regulator of the early innate γδ T cell response to mucosal injury.

Details

Language :
English
ISSN :
1529-2916
Volume :
21
Issue :
11
Database :
MEDLINE
Journal :
Nature immunology
Publication Type :
Academic Journal
Accession number :
32989331
Full Text :
https://doi.org/10.1038/s41590-020-0785-3